Company: TOMZ
Filing Date: 2025-11-14
Form Type: S-3
Source: 0001654954-25-013109
Chunk: 13

Company: TOMI Environmental Solutions, Inc.
Filing Date: 2025-11-14
Form: S-3
Chunk 13
---
 had reasonable cause to believe his or her conduct was lawful or had no reasonable cause to believe his or her conduct was unlawful, or (d) in the case of a director, a circumstance under which the director would be liable under the FBCA for an unlawful distribution. Our amended bylaws do not provide for the indemnification of our current and former directors and officers, thus the only right of indemnification that our current and former directors and officers have is a right of indemnification should such director or officer succeed against a claim brought against them because they were a director or officer as set out under FBCA § 607.0852. We have obtained a directors’ and officers’ liability insurance policy covering its current and former directors and officers.

Listing

Our Common Stock is currently listed on the NASDAQ under the symbol “TOMZ”.

Transfer Agent and Registrar

The transfer agent and registrar for our Common Stock is Continental Stock Transfer & Trust Company.

| 7 |

<div align='center'>DESCRIPTION OF PREFERRED STOCK</div>

We are currently authorized to issue 1,000,000 shares of cumulative series A preferred stock, par value $0.01 per share (the “Series A Preferred Stock”), and 4,000 shares of cumulative series B preferred stock, $1,000 stated value (the “Series B Preferred Stock”). Our Board will be authorized to establish the voting rights, if any, designations, preferences and relative, participating, optional or other special rights of the shares of such series, and the qualifications, limitations or restrictions thereof, applicable to the shares of each series of our Preferred Stock. Our Board can, without stockholder approval, issue our Preferred Stock with voting and other rights that could adversely affect the voting power and other rights of the holders of our Common Stock and could have anti-takeover effects. The ability of our Board to issue our Preferred Stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control or the removal of existing management. As of November 14, 2025, we have 63,750 shares of Series A Preferred Stock and no Series B Preferred Stock issued and outstanding.

| 8 |

<div align='center'>DESCRIPTION OF WARRANTS</div>

The following summarizes the general terms of stock and debt warrants that we may offer. The particular terms of any stock and debt warrants will be described in an accompanying prospectus supplement. The description below and in any accompanying prospectus supplement is not complete. You should read the form of